Lessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent Glioblastoma
Year: 2026
Type: editorial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-00444
Author: Karla V. Ballman
Institution: Mayo Clinic
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7160962457
